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The stereochemically constrained chemotactic peptide analogs, formylmethionyl-cr-aminoisobutyryl- 
phenylalanine (formyl-Met-Aib-Phe-OH) and formylmethionylcycloleucinylphenylalanine (formyl-Met- 
Cyl-Phe-OH) are highly effective in inducing lysosomal enzyme release from rabbit neutrophils. NMR 
studies of the Aib’ analog in (CD&SO favor a folded conformation in which the Phe NH group is 
inacessible to solvent. Intramolecularly hydrogen-bonded conformations involving a Met-Aib-&turn or a 
y-turn centered at Aib2 are considered. The results suggest hat folded conformations may allow highly 
active interactions with the neutrophil formylpeptide receptor. 
Chemotactic peptide Neutrophil 
1. INTRODUCTION 
The finding that low molecular mass tripeptides 
are chemoattractants for neutrophils which also in- 
duce selective release of lysosomal enzymes [1,2] 
has stimulated considerable interest in developing 
models for the biologically active conformation of 
these peptides [3-51. Extensive ‘H and 13C NMR 
relaxation studies of the most active member of 
this class of peptides N-formyl-Met-Leu-Phe-OH 
(FMLP) have suggested an extended, monomeric 
P-sheet conformation in dimethyl sulfoxide solu- 
tion [3]. The observation of a low temperature 
coefficient (ds/dT) value for the Phe NH proton in 
the anionic form of FMLP in (CD&SO did pro- 
vide some evidence, albeit weak, for the possibility 
of a folded structure in which the Phe NH group 
was shielded from the solvent. However, this con- 
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formation was ruled out as it was incompatible 
with the analysis of relaxation data in terms of in- 
terproton distances [3]. On the basis of structure- 
activity data involving analysis of results from a 
large number of analog peptides, an extended p- 
sheet conformation has been tentatively suggested 
as the biologically active form of the chemotactic 
peptide, FMLP [6]. In order to test this hypothesis, 
we report studies on conformationally constrained 
analogs, in which the central Leu residue is replac- 
ed by an a, a-dialkyl amino acid, a-aminoiso- 
butyric acid (Aib) or cycloleucine (I-aminocyclo- 
pentane-1-carboxylic a id, Cyl). The results suggest 
that ‘active’ conformations may be folded at the 
receptor site. 
2. MATERIALS AND METHODS 
Peptides were synthesized by conventional solu- 
tion phase procedures [7]. All peptides were 
chromatographically pure as judged by thin layer 
chromatography in three solvent systems (n- 
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Fig. 1. The Aib (a) and Cyl (b) residues in a peptide 
chain. 
butanol-acetic acid-water, 4: 1: 1; chloroform- 
methanol-acetic acid-water, 65 : 30 : 4 : 1; benzene- 
acetic acid-water, 9: 9: 1) and yielded fully consis- 
tent 270 MHz ‘H NMR spectra. 
The peptides were tested for their ability to in- 
duce release of the lysosomal enzymes, & 
glucuronidase and lysozyme from cytochalasin B- 
treated rabbit neutrophils, as in [2]. 
270 MHz ‘H NMR spectra were recorded on a 
Bruker WH-270 FT NMR spectrometer at the 
Sophisticated Instruments Facility, Bangalore. 
NMR samples were prepared by directly dissolving 
solid peptide in (CD&SO, at a concentration of 10 
mglml . 
3. RESULTS AND DISCUSSION 
The analogs formyl-Met-Aib-Phe and formyl- 
Met-Cyl-Phe were synthesized with the view of im- 
posing stereochemical restrictions on backbone 
folding. CY, tr-Dialkyl a-amino acids preferentially 
adopt only a limited range of conformations due to 
unfavorable steric contacts involving atoms on the 
two flanking peptide units (fig. l), with the geminal 
substituents at C” [f&9]. Extensive crystallo- 
graphic, spectroscopic and theoretical studies on 
Aib peptides [lo-131 have provided strong support 
for the overwhelming preference of this residue for 
4, + values in the right- and left-handed ~,D/LY- 
helical regions of the Ramachandran map 
(4 t 60” + 20”, + f 30” I 20”) [ 14]. In small pep- 
tides, 4-+1 hydrogen-bonded &turns have been 
almost exclusively found for Aib-X and X-Aib se- 
quences [11,12]. This residue occurs with con- 
siderably lower frequency in the y-turn (in- 
tramolecular 3-l hydrogen bond) conformation 
((s + 80”, $ T 80”) although this is sterically allowed 
and only slightly higher in energy than structures in 
the helical region [l 1). Cyl is expected to behave in 
a similar fashion since it also possesses two alkyl 
substituents at the C* atom. 
Table 1 summarizes the results of the neutrophil 
lysosomal enzyme release assay on FMLP and a 
few analogs. It is clearly seen that both the analogs 
incorporating Aib or Cyl at position 2 are highly 
active. The data in table 1 also provide additional 
support for the view that the C-terminal carboxylic 
acid group is not essential for activity [4,15], as 
demonstrated by the low JZ&-, values for the ester 
and amide analogs of FMLP. Replacement of the 
formyl group by a t-butyloxycarbonyl (Boc) func- 
tion leads to a dramatic attenuation of activity in 
the position 2 analogs [5]. This is confirmed by the 
low activity of Boc-Met-~yl-Phe-OH. 
270 MHz ‘H NMR studies were carried out on 
the peptides formyl-Met-Leu-Phe-OH and formyl- 
Met-Aib-Phe-OH, in order to compare spec- 
troscopic properties in solution. The chemical 
Table 1 
EL& (M) values for peptide-induced lysosqmal enzyme release 
Peptide Lysozyme &Glucuronidase 
Formyl-Met-Leu-Phe-OH (1.5*0.5)x lo-I0 (2.0*1.0)x lo-‘O 
Formyl-Met-Aib-Phe-OH (1.9+0.8)x 1o-9 (2.9 + 1.4) x lo-’ 
Formyl-Met-Cyl-Phe-OH (3.9k 0.7) x lo-‘O (6.1 f 1.9)x lo-*’ 
Formyl-Met-Leu-Phe-OMe (3.2-t 1.5)x lo-” (3.6+2.0)x 10”” 
Formyl-Met-Leu-Phe-NH2 (1.2+-0.7)x 10-l’ “(4.2+1.0)x 10-I’ 
Boc-Met-Cyl-Phe-OH (5.5 -+ 0.8) x lo-’ (6.7 +0.9) x IO-’ 
,!?I&,, concentration of peptide required to produce 5O”fo f the maximum effect deter- 
mined by the concentration effect curve. Each value is the average +SE of 3 
determinations 
a Averaged over 2 determinations 
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Table 2 
Chemical shifts and temperature coefficients for NH group? 
Peptide Met Leu/Aib Phe 
Formyl-Met-Leu-Phe-OHb 6 8.08 8.01 8.25 
ds/dT 0.0052 0.0044 0.0039 
(0.0041) (0.0045) (0.0061) 
(0.0085) (0.0085) (0.0026) 
Formyl-Met-Aib-Phe-OH 6 8.36 8.11 7.48 
ds/dT 0.0050 0.0045 0.0027 
a Parameters determined in (CD&SO. dUdT values expressed as ppm/“C. 
b &/dT values in parentheses are from [3]. Upper values are for a sample lyophilized 
from aqueous solution at pH 2. Lower values correspond to pH 8. Values deter- 
mined in (CD&SO 
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shifts (6,ppm) and temperature coefficient (&/dT) 
values for the various NH groups in (CD3)2SO are 
summarized in table 2. The values obtained in an 
earlier study of FMLP [3] are provided for com- 
parison. In both peptides the Phe NH resonance 
has a significantly lower dUdTvalue as compared 
to the NH resonances of residues 1 and 2. Low 
ds/dT values (<0.003 ppm/“C) in (CD3)2SO are 
generally indicative of solvent shielded (presum- 
ably intramolecularly hydrogen-bonded) NH 
groups [16]. The value of 0.0027 ppm/“C obtained 
for Phe NH in formyl-Met-Aib-Phe is low enough 
to argue for its inaccessibility to solvent. Together 
with the known propensity of Aib residues for 
folded, hydrogen-bonded conformations, the 
NMR data support the existence of folded struc- 
tures, involving Phe NH in an intramolecular 
hydrogen bond. 
Two structures may be considered as feasible. 
These are the 4+ 1 hydrogen-bonded Met-Aib p- 
turn and the 3+ 1 hydrogen bonded y-turn 
centered at Aib (fig.2). In both structures the Phe 
(0) (b) 
Fig. 2. Hydrogen-bonded conformations of formyl-Met- 
Aib-Phe-OH involving Phe NH. (a) Met-Aib &turn. (b) 
y-turn centered at Aib. 
NH is hydrogen-bonded and the two possibilities 
differ only in the nature of the acceptor C=O 
group. Theoretical analysis of Aib residues sug- 
gests that the differences in energies for the &turn 
(4- *60”, +20”, $- ~30”~20”; i+2 residue in 
type III(I) or III’(1’) and type II or II’ &turns) 
and a y-turn conformation (4 + - SO’+- + 80”) is 
3 kcal . mol-’ [ 111. This is small enough to be off- 
set by other interactions. While several examples 
of @turn structures are documented in the solid 
state [ 10-131, the P-turn has been observed 
crystallographically in the cyclic peptide dihy- 
drochlamydocin [17]. C7 conformations have also 
been proposed for solution IR studies of small Aib 
peptides [ 181 and considered for (Aib-Pro),, se- 
quences [19,201. The earlier proposal of an ‘active’ 
P-sheet conformation [6] requires the conforma- 
tional angles at residue 2 to have values of 42 = 
- 140”, &= 140”. In fact, the NMR relaxation 
analysis for FMLP suggest families of solution 
conformations with 42 = - 120”, $2 = 161” or 
42 = - 135”, #Z = 120” [3]. These values are incom- 
patible with the known stereochemical preferences 
of Aib residues [10-131. Theoretical estimates ug- 
gest that the ideal antiparallel P-sheet conforma- 
tion is 10 kcal - mol-’ less stable than a helical con- 
formation for Aib residues [l 1). The observation 
of high biological activity for the Aib2 and Cy12 
analogs implies that extended structures may not 
be essential in mediating receptor interactions. The 
higher activity of the Cy12 analog as compared to 
the Aib’ peptide may reflect favorable interactions 
between a bulky hydrocarbon side chain at residue 
2 and a hydrophobic receptor site. The Aib’ is 
173 
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about lo-times, the Cyl’ derivative 2.5-3-times, 
less active than FMLP. This suggests that a folded 
conformation although capable of giving high ac- 
tivity is not compatible with the optimal activity 
given by the extended conformation presumabIy 
present in FMLP. Alternatively, it is possible that 
the lower activities reflect the less than optimal side 
chain interactions of the Aib’ and Cy12 derivatives 
with the receptor site compared to the correspon- 
ding side chain of FMLP. 
It is interesting to note that the Phe NH in 
FMLP also has a relatively low ds/dTvalue, which 
suggests a measure of shielding from the solvent. 
The value is, however, not low enough to favor 
definitively involvement in an intramolecular 
hydrogen bond. The ds/dT values obtained for 
Phe NH in FMLP, in the present study, differ 
from those reported earlier (table 2). However, the 
mode of sample preparation in the earlier study 
was distinctly different, involving dissolving the 
peptide in aqueous media at pH 2 or 8, followed by 
lyophilization and redissolution in (CD&SO [3)]. 
It is likely that FMLP does favor an extended con- 
formation in (CD&SO, although populations of 
folded structures could be considered. 
Our results establish that chemotactic peptide 
analogs which favor folded backbone conforma- 
tions are biologicahy highly active. It would thus 
appear that the nature of the receptor bound con- 
formation of the chemotactic peptide remains to 
be established. Further speculative hypotheses may 
stimulate additional experimental investigations. 
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